← back to search

Vivian Viallon

Université Claude Bernard Lyon 1 · FR
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Medicine, European Prospective Investigation into Cancer and Nutrition, Prospective cohort study, Cancer, Breast cancer, and Internal medicine.
h-index
citations
3,103
works
78
NIH funding
primary concept
email

Recent publications

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research
ESMO rare cancers. 2025cited by 3position: middledoi
EPIC4ND: European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases
medRxiv 2025cited by 3position: middledoi
Plasma proteomics in the prediagnostic phase of Parkinson’s disease: a multi-cohort study of 74,000 participants
medRxiv 2025cited by 2position: middledoi
Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk?
Cancer & Metabolism 2025cited by 1position: middledoi
Proteomics signature of physical activity and risk of multimorbidity of cancer and cardiometabolic diseases
medRxiv 2025cited by 0position: middledoi
Adiposity, mortality, and disease risk: insights from bioimpedance analysis and magnetic resonance imaging
BMC Medicine 2025cited by 0position: lastdoi
Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study
BMC Medicine 2024cited by 26position: middledoi
Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case–control study in the European Prospective Investigation into Cancer and Nutrition (EPIC)
EBioMedicine 2024cited by 20position: middledoi
Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort
BMC Medicine 2024cited by 18position: middledoi
Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank
BMC Medicine 2024cited by 15position: middledoi
On the use of the healthy lifestyle index to investigate specific disease outcomes
Scientific Reports 2024cited by 13position: firstdoi
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses
EBioMedicine 2024cited by 12position: middledoi
Degree of food processing and breast cancer risk: a prospective study in 9 European countries
Food Production Processing and Nutrition 2024cited by 9position: middledoi
Tissue-specific genetic variation suggests distinct molecular pathways between body shape phenotypes and colorectal cancer
Science Advances 2024cited by 6position: middledoi
Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study
Cancer Communications 2024cited by 5position: middledoi
Nature or nurture: genetic and environmental predictors of adiposity gain in adults
EBioMedicine 2024cited by 4position: middledoi
Body Shapes of Multiple Anthropometric Traits and All-cause and Cause-specific Mortality in the UK Biobank
Epidemiology 2024cited by 2position: middledoi
Nature or Nurture: Genetic and Environmental Predictors of Adiposity Gain in Adults
SSRN Electronic Journal 2024cited by 0position: middledoi
Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study
The Lancet Regional Health - Europe 2023cited by 200position: middledoi
Food processing and cancer risk in Europe: results from the prospective EPIC cohort study
The Lancet Planetary Health 2023cited by 107position: middledoi
Longitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults
Nature Communications 2023cited by 75position: middledoi
Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts
BMC Medicine 2023cited by 47position: middledoi
Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies
BMC Medicine 2023cited by 45position: middledoi
Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Clinical Nutrition 2023cited by 28position: middledoi
Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis
European Journal of Nutrition 2023cited by 23position: middledoi
Association between circadian physical activity patterns and mortality in the UK Biobank
International Journal of Behavioral Nutrition and Physical Activity 2023cited by 7position: middledoi
Body Shape Phenotypes and Breast Cancer Risk: A Mendelian Randomization Analysis
Cancers 2023cited by 7position: middledoi
On the use of the healthy lifestyle index to investigate specific disease outcomes
Research Square 2023cited by 1position: firstdoi
Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C‐reactive protein, fasting insulin, and estradiol
Cancer Medicine 2022cited by 40position: middledoi
Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition
BMC Medicine 2022cited by 38position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Marc J. Gunter · World Health Organization - Lyon Office16 papers (2015–2025)Pietro Ferrari · Centre international de recherche sur le cancer12 papers (2015–2025)Heinz Freisling · Centre International de Recherche sur le Cancer10 papers (2022–2025)Béatrice Fervers · University of Regensburg8 papers (2022–2025)Michael F. Leitzmann · University of Regensburg8 papers (2018–2025)Anja M. Sedlmeier · University of Regensburg7 papers (2022–2025)Laia Peruchet‐Noray · Universitat de Barcelona7 papers (2022–2025)Michael J. Stein · University of Regensburg5 papers (2022–2025)Hansjörg Baurecht · Technical University of Munich5 papers (2022–2025)Patricia Bohmann · University of Regensburg5 papers (2022–2025)Augustin Scalbert · Centre International de Recherche sur le Cancer5 papers (2018–2021)Emma Fontvieille · Centre international de recherche sur le cancer5 papers (2022–2025)Marie‐Christine Boutron‐Ruault · Université Paris-Sud4 papers (2018–2021)Tilman Kühn · University of Vienna4 papers (2015–2019) · 3 papers (2024–2025)Verena Katzke · Leibniz Institute for Prevention Research and Epidemiology - BIPS3 papers (2021–2025)Inge Huybrechts · Pancreatic Cancer Action Network3 papers (2019–2021)Robert Carreras‐Torres · Universitat de Barcelona3 papers (2022–2023)Julian Konzok · University of Regensburg3 papers (2022–2024)Christina Bamia · National and Kapodistrian University of Athens3 papers (2015–2018)